IBDEI0I8 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,8202,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8202,1,3,0)
;;=3^Thyroiditis,Subacute
;;^UTILITY(U,$J,358.3,8202,1,4,0)
;;=4^E06.1
;;^UTILITY(U,$J,358.3,8202,2)
;;=^119376
;;^UTILITY(U,$J,358.3,8203,0)
;;=C73.^^39^394^19
;;^UTILITY(U,$J,358.3,8203,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8203,1,3,0)
;;=3^Malig Neop of Thyroid Gland
;;^UTILITY(U,$J,358.3,8203,1,4,0)
;;=4^C73.
;;^UTILITY(U,$J,358.3,8203,2)
;;=^267296
;;^UTILITY(U,$J,358.3,8204,0)
;;=E16.2^^39^394^10
;;^UTILITY(U,$J,358.3,8204,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8204,1,3,0)
;;=3^Hypoglycemia,Unspec
;;^UTILITY(U,$J,358.3,8204,1,4,0)
;;=4^E16.2
;;^UTILITY(U,$J,358.3,8204,2)
;;=^5002708
;;^UTILITY(U,$J,358.3,8205,0)
;;=E20.0^^39^394^15
;;^UTILITY(U,$J,358.3,8205,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8205,1,3,0)
;;=3^Idiopathic Hypoparathyroidism
;;^UTILITY(U,$J,358.3,8205,1,4,0)
;;=4^E20.0
;;^UTILITY(U,$J,358.3,8205,2)
;;=^5002712
;;^UTILITY(U,$J,358.3,8206,0)
;;=E20.9^^39^394^11
;;^UTILITY(U,$J,358.3,8206,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8206,1,3,0)
;;=3^Hypoparathyroidism,Unspec
;;^UTILITY(U,$J,358.3,8206,1,4,0)
;;=4^E20.9
;;^UTILITY(U,$J,358.3,8206,2)
;;=^5002714
;;^UTILITY(U,$J,358.3,8207,0)
;;=E23.0^^39^394^12
;;^UTILITY(U,$J,358.3,8207,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8207,1,3,0)
;;=3^Hypopituitarism
;;^UTILITY(U,$J,358.3,8207,1,4,0)
;;=4^E23.0
;;^UTILITY(U,$J,358.3,8207,2)
;;=^60685
;;^UTILITY(U,$J,358.3,8208,0)
;;=E27.1^^39^394^34
;;^UTILITY(U,$J,358.3,8208,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8208,1,3,0)
;;=3^Primary Adrenocortical Insufficiency
;;^UTILITY(U,$J,358.3,8208,1,4,0)
;;=4^E27.1
;;^UTILITY(U,$J,358.3,8208,2)
;;=^5002740
;;^UTILITY(U,$J,358.3,8209,0)
;;=E27.2^^39^394^1
;;^UTILITY(U,$J,358.3,8209,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8209,1,3,0)
;;=3^Addisonian Crisis
;;^UTILITY(U,$J,358.3,8209,1,4,0)
;;=4^E27.2
;;^UTILITY(U,$J,358.3,8209,2)
;;=^263725
;;^UTILITY(U,$J,358.3,8210,0)
;;=E27.3^^39^394^4
;;^UTILITY(U,$J,358.3,8210,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8210,1,3,0)
;;=3^Drug-induced Adrenocortical Insufficiency
;;^UTILITY(U,$J,358.3,8210,1,4,0)
;;=4^E27.3
;;^UTILITY(U,$J,358.3,8210,2)
;;=^5002741
;;^UTILITY(U,$J,358.3,8211,0)
;;=E29.1^^39^394^35
;;^UTILITY(U,$J,358.3,8211,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8211,1,3,0)
;;=3^Testicular Hypofunction
;;^UTILITY(U,$J,358.3,8211,1,4,0)
;;=4^E29.1
;;^UTILITY(U,$J,358.3,8211,2)
;;=^5002754
;;^UTILITY(U,$J,358.3,8212,0)
;;=E55.9^^39^394^42
;;^UTILITY(U,$J,358.3,8212,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8212,1,3,0)
;;=3^Vitamin D Deficiency,Unspec
;;^UTILITY(U,$J,358.3,8212,1,4,0)
;;=4^E55.9
;;^UTILITY(U,$J,358.3,8212,2)
;;=^5002799
;;^UTILITY(U,$J,358.3,8213,0)
;;=E66.01^^39^394^20
;;^UTILITY(U,$J,358.3,8213,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8213,1,3,0)
;;=3^Morbid Obesity
;;^UTILITY(U,$J,358.3,8213,1,4,0)
;;=4^E66.01
;;^UTILITY(U,$J,358.3,8213,2)
;;=^5002826
;;^UTILITY(U,$J,358.3,8214,0)
;;=E66.8^^39^394^24
;;^UTILITY(U,$J,358.3,8214,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8214,1,3,0)
;;=3^Obesity NEC
;;^UTILITY(U,$J,358.3,8214,1,4,0)
;;=4^E66.8
;;^UTILITY(U,$J,358.3,8214,2)
;;=^5002831
;;^UTILITY(U,$J,358.3,8215,0)
;;=E66.9^^39^394^25
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0I8 3751 printed Oct 16, 2024@17:50:02 Page 2
IBDEI0I8 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,8202,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,8202,1,3,0)
+4 ;;=3^Thyroiditis,Subacute
+5 ;;^UTILITY(U,$J,358.3,8202,1,4,0)
+6 ;;=4^E06.1
+7 ;;^UTILITY(U,$J,358.3,8202,2)
+8 ;;=^119376
+9 ;;^UTILITY(U,$J,358.3,8203,0)
+10 ;;=C73.^^39^394^19
+11 ;;^UTILITY(U,$J,358.3,8203,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,8203,1,3,0)
+14 ;;=3^Malig Neop of Thyroid Gland
+15 ;;^UTILITY(U,$J,358.3,8203,1,4,0)
+16 ;;=4^C73.
+17 ;;^UTILITY(U,$J,358.3,8203,2)
+18 ;;=^267296
+19 ;;^UTILITY(U,$J,358.3,8204,0)
+20 ;;=E16.2^^39^394^10
+21 ;;^UTILITY(U,$J,358.3,8204,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,8204,1,3,0)
+24 ;;=3^Hypoglycemia,Unspec
+25 ;;^UTILITY(U,$J,358.3,8204,1,4,0)
+26 ;;=4^E16.2
+27 ;;^UTILITY(U,$J,358.3,8204,2)
+28 ;;=^5002708
+29 ;;^UTILITY(U,$J,358.3,8205,0)
+30 ;;=E20.0^^39^394^15
+31 ;;^UTILITY(U,$J,358.3,8205,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,8205,1,3,0)
+34 ;;=3^Idiopathic Hypoparathyroidism
+35 ;;^UTILITY(U,$J,358.3,8205,1,4,0)
+36 ;;=4^E20.0
+37 ;;^UTILITY(U,$J,358.3,8205,2)
+38 ;;=^5002712
+39 ;;^UTILITY(U,$J,358.3,8206,0)
+40 ;;=E20.9^^39^394^11
+41 ;;^UTILITY(U,$J,358.3,8206,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,8206,1,3,0)
+44 ;;=3^Hypoparathyroidism,Unspec
+45 ;;^UTILITY(U,$J,358.3,8206,1,4,0)
+46 ;;=4^E20.9
+47 ;;^UTILITY(U,$J,358.3,8206,2)
+48 ;;=^5002714
+49 ;;^UTILITY(U,$J,358.3,8207,0)
+50 ;;=E23.0^^39^394^12
+51 ;;^UTILITY(U,$J,358.3,8207,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,8207,1,3,0)
+54 ;;=3^Hypopituitarism
+55 ;;^UTILITY(U,$J,358.3,8207,1,4,0)
+56 ;;=4^E23.0
+57 ;;^UTILITY(U,$J,358.3,8207,2)
+58 ;;=^60685
+59 ;;^UTILITY(U,$J,358.3,8208,0)
+60 ;;=E27.1^^39^394^34
+61 ;;^UTILITY(U,$J,358.3,8208,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,8208,1,3,0)
+64 ;;=3^Primary Adrenocortical Insufficiency
+65 ;;^UTILITY(U,$J,358.3,8208,1,4,0)
+66 ;;=4^E27.1
+67 ;;^UTILITY(U,$J,358.3,8208,2)
+68 ;;=^5002740
+69 ;;^UTILITY(U,$J,358.3,8209,0)
+70 ;;=E27.2^^39^394^1
+71 ;;^UTILITY(U,$J,358.3,8209,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,8209,1,3,0)
+74 ;;=3^Addisonian Crisis
+75 ;;^UTILITY(U,$J,358.3,8209,1,4,0)
+76 ;;=4^E27.2
+77 ;;^UTILITY(U,$J,358.3,8209,2)
+78 ;;=^263725
+79 ;;^UTILITY(U,$J,358.3,8210,0)
+80 ;;=E27.3^^39^394^4
+81 ;;^UTILITY(U,$J,358.3,8210,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,8210,1,3,0)
+84 ;;=3^Drug-induced Adrenocortical Insufficiency
+85 ;;^UTILITY(U,$J,358.3,8210,1,4,0)
+86 ;;=4^E27.3
+87 ;;^UTILITY(U,$J,358.3,8210,2)
+88 ;;=^5002741
+89 ;;^UTILITY(U,$J,358.3,8211,0)
+90 ;;=E29.1^^39^394^35
+91 ;;^UTILITY(U,$J,358.3,8211,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,8211,1,3,0)
+94 ;;=3^Testicular Hypofunction
+95 ;;^UTILITY(U,$J,358.3,8211,1,4,0)
+96 ;;=4^E29.1
+97 ;;^UTILITY(U,$J,358.3,8211,2)
+98 ;;=^5002754
+99 ;;^UTILITY(U,$J,358.3,8212,0)
+100 ;;=E55.9^^39^394^42
+101 ;;^UTILITY(U,$J,358.3,8212,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,8212,1,3,0)
+104 ;;=3^Vitamin D Deficiency,Unspec
+105 ;;^UTILITY(U,$J,358.3,8212,1,4,0)
+106 ;;=4^E55.9
+107 ;;^UTILITY(U,$J,358.3,8212,2)
+108 ;;=^5002799
+109 ;;^UTILITY(U,$J,358.3,8213,0)
+110 ;;=E66.01^^39^394^20
+111 ;;^UTILITY(U,$J,358.3,8213,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,8213,1,3,0)
+114 ;;=3^Morbid Obesity
+115 ;;^UTILITY(U,$J,358.3,8213,1,4,0)
+116 ;;=4^E66.01
+117 ;;^UTILITY(U,$J,358.3,8213,2)
+118 ;;=^5002826
+119 ;;^UTILITY(U,$J,358.3,8214,0)
+120 ;;=E66.8^^39^394^24
+121 ;;^UTILITY(U,$J,358.3,8214,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,8214,1,3,0)
+124 ;;=3^Obesity NEC
+125 ;;^UTILITY(U,$J,358.3,8214,1,4,0)
+126 ;;=4^E66.8
+127 ;;^UTILITY(U,$J,358.3,8214,2)
+128 ;;=^5002831
+129 ;;^UTILITY(U,$J,358.3,8215,0)
+130 ;;=E66.9^^39^394^25